Vanguard Group’s MGC Diagnostics MGCD Stock Holding History
Bought
Maintained
Sold
Other funds holding MGCD
KPF
Vanguard Group's MGCD Position: Q4 2017 in Review
Vanguard Group sold out of MGC Diagnostics (MGCD) in Q4 2017, closing a stake of 80,771 shares — an estimated $724K sold.
Vanguard Group first reported a position in MGCD in Q2 2013 and held it in 18 quarters. The position peaked at $724K in Q3 2017. 12 funds tracked by Wall St. Rank hold MGCD as of Q4 2017.
- Vanguard Group reported no remaining MGC Diagnostics position as of Q4 2017 after selling out during the quarter.
- Vanguard Group sold 80,771 MGC Diagnostics shares in Q4 2017, an estimated $724K.
- Vanguard Group first reported a position in MGC Diagnostics in Q2 2013 and held it in 18 quarters.
- Vanguard Group's MGC Diagnostics position peaked at $724K in Q3 2017.
- 12 funds tracked by Wall St. Rank held MGC Diagnostics as of Q4 2017.
Based on Vanguard Group's 13F filing for Q4 2017, filed 14 Feb 2018.